Emergent BioSolutions (EBS) Non Operating Income (2011 - 2026)

Emergent BioSolutions' Non Operating Income history runs 16 years deep, the most recent figure standing at $2.9 million for Q1 2026.

• In Q1 2026, Non Operating Income fell 95.84% year-over-year to $2.9 million; the TTM figure through Mar 2026 stood at -$42.0 million (down 683.33% YoY), while the FY2025 annual figure was -$17.3 million, up 49.42% from the prior year.
• Non Operating Income was $2.9 million for Q1 2026 at Emergent BioSolutions, up from -$22.8 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $69.7 million in Q1 2025 to a low of -$66.3 million in Q2 2024.
• Historically, Non Operating Income has averaged -$7.9 million across 5 years, with a median of -$3.7 million in 2025.
• The sharpest annual moves came in 2022 and 2025: Non Operating Income sank 3300.0% in 2022, then jumped 351.62% in 2025.
• A 5-year view of Non Operating Income shows it stood at -$30.6 million in 2022, then surged by 127.78% to $8.5 million in 2023, then plunged by 312.94% to -$18.1 million in 2024, then retreated by 25.97% to -$22.8 million in 2025, then jumped by 112.72% to $2.9 million in 2026.
• The last three Non Operating Income figures came in at $2.9 million (Q1 2026), -$22.8 million (Q4 2025), and -$3.7 million (Q3 2025), per Business Quant data.